Camizestrant plus a CDK4/6 inhibitor established ctDNA-detected emergent ESR1 mutation as an on-treatment switch trigger, improving PFS versus continuing initial endocrine therapy. Sevabertinib ...
A headline about a "breakthrough cancer vaccine" is bound to raise a big question: Can it actually cure cancer? That's what many patients are wondering after Moderna and Merck announced promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results